BioAdaptives Inc (BDPT)

[Max2121]

Fear mongering at its best.

The company( BDPT) has not paid
$400,000 for the patent yet. It is clear and explicitly written “option”.

Reading &understanding one thing, but misrepresentation is a manipulation.

The option to buy does not mean paid
$400,000. All it is BDPT has an option to purchase. IMO they are going to walk away or they extend, change the agreement
prior 2/2/2024. IMO…

“Effective February 2, 2022, the Company entered into a Patent Purchase Agreement and Consulting Agreement with Thomas J. Mohr. Under the Agreement, the Company has the exclusive option to purchase Mohr’s U.S. Patent No. 9,783,432B (the “Patent”), which covers technology used in enhancing the capability of water to hold significantly larger amounts of oxygen, for a two-year period. The option price is $400,000. The Agreement furthermore allows the Company a two-year license to use the technology covered by the Patent, including for further development of oxygenated water products for consumers. In exchange for the license, the Company will pay Mohr a royalty, scaled to total product sales. “